Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion
Identifieur interne : 002346 ( Main/Exploration ); précédent : 002345; suivant : 002347Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion
Auteurs : A. Espino [Espagne] ; J. Llorens [Espagne] ; M. Calopa [Espagne] ; R. Bartrons [Espagne] ; E. Rodriguez-Farre [Espagne] ; S. Ambrosio [Espagne]Source :
- Brain Research [ 0006-8993 ] ; 1994.
English descriptors
- KwdEn :
Abstract
Dopamine (DA) and its main cerebral metabolites, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) were measured in striatum and cerebrospinal fluid (CSF) from cisterna magna in rats bilaterally lesioned by intrastriatal administration of 6-hydroxydopamine (6-OHDA) or 1-methyl-4-phenylpyridinium ion (MPP+). 6-OHDA caused a progressive lesion in striatum that is only moderately reflected in the decrease in dopamine metabolite concentration in CSF. MPP+ caused an acute but less selective lesion in the dopamine striatal system, as indicated by a significant reduction in striatal GABA content, followed by a slow recovery in dopamine striatal metabolism and content. The locomotor activity was dramatically reduced in both groups 48 hours after the treatment but remained significantly decreased after two months only in 6-OHDA lesioned animals. A positive correlation was found between HVA CSF concentration and striatal DA content in MPP+ lesioned rats, but not in 6-OHDA lesioned rats. It is concluded that the concentration of dopamine metabolites in CSF can be altered only after a severe striatal lesion: reduction of striatal dopamine content below 50% of normal values and involvement of neuronal or non-neuronal elements other than the dopaminergic system, similarly to the lesions caused by MPP+. These results may partly explain why CSF dopamine metabolites concentrations were significantly decreased both in advanced stages of parkinsonism and in other neurodegenerative disorders.
Url:
DOI: 10.1016/0006-8993(94)01217-6
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion</title><author><name sortKey="Espino, A" sort="Espino, A" uniqKey="Espino A" first="A." last="Espino">A. Espino</name></author><author><name sortKey="Llorens, J" sort="Llorens, J" uniqKey="Llorens J" first="J." last="Llorens">J. Llorens</name></author><author><name sortKey="Calopa, M" sort="Calopa, M" uniqKey="Calopa M" first="M." last="Calopa">M. Calopa</name></author><author><name sortKey="Bartrons, R" sort="Bartrons, R" uniqKey="Bartrons R" first="R." last="Bartrons">R. Bartrons</name></author><author><name sortKey="Rodriguez Farre, E" sort="Rodriguez Farre, E" uniqKey="Rodriguez Farre E" first="E." last="Rodriguez-Farre">E. Rodriguez-Farre</name></author><author><name sortKey="Ambrosio, S" sort="Ambrosio, S" uniqKey="Ambrosio S" first="S." last="Ambrosio">S. Ambrosio</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:1A3EDCFD79687759F33CB8A711F24AD90AE488FC</idno><date when="1995" year="1995">1995</date><idno type="doi">10.1016/0006-8993(94)01217-6</idno><idno type="url">https://api.istex.fr/document/1A3EDCFD79687759F33CB8A711F24AD90AE488FC/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002F76</idno><idno type="wicri:Area/Main/Curation">002B86</idno><idno type="wicri:Area/Main/Exploration">002346</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion</title><author><name sortKey="Espino, A" sort="Espino, A" uniqKey="Espino A" first="A." last="Espino">A. Espino</name><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Unit of Biochemistry, Campus of Bellvitge, University of Barcelona, Barcelona </wicri:regionArea><wicri:noRegion>Barcelona </wicri:noRegion></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Unit of Neurology, Hospital Pri´nceps d'Espanya, Barcelona </wicri:regionArea><wicri:noRegion>Barcelona </wicri:noRegion></affiliation></author><author><name sortKey="Llorens, J" sort="Llorens, J" uniqKey="Llorens J" first="J." last="Llorens">J. Llorens</name><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Pharmacology and Toxicology, CSIC, Barcelona </wicri:regionArea><wicri:noRegion>Barcelona </wicri:noRegion></affiliation></author><author><name sortKey="Calopa, M" sort="Calopa, M" uniqKey="Calopa M" first="M." last="Calopa">M. Calopa</name><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Unit of Neurology, Hospital Pri´nceps d'Espanya, Barcelona </wicri:regionArea><wicri:noRegion>Barcelona </wicri:noRegion></affiliation></author><author><name sortKey="Bartrons, R" sort="Bartrons, R" uniqKey="Bartrons R" first="R." last="Bartrons">R. Bartrons</name><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Unit of Biochemistry, Campus of Bellvitge, University of Barcelona, Barcelona </wicri:regionArea><wicri:noRegion>Barcelona </wicri:noRegion></affiliation></author><author><name sortKey="Rodriguez Farre, E" sort="Rodriguez Farre, E" uniqKey="Rodriguez Farre E" first="E." last="Rodriguez-Farre">E. Rodriguez-Farre</name><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Pharmacology and Toxicology, CSIC, Barcelona </wicri:regionArea><wicri:noRegion>Barcelona </wicri:noRegion></affiliation></author><author><name sortKey="Ambrosio, S" sort="Ambrosio, S" uniqKey="Ambrosio S" first="S." last="Ambrosio">S. Ambrosio</name><affiliation><wicri:noCountry code="subField">Spain. Fax: (34) (3) 402 4212.</wicri:noCountry></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Unit of Biochemistry, Campus of Bellvitge, University of Barcelona, Barcelona </wicri:regionArea><wicri:noRegion>Barcelona </wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Brain Research</title><title level="j" type="abbrev">BRES</title><idno type="ISSN">0006-8993</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1994">1994</date><biblScope unit="volume">669</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="19">19</biblScope><biblScope unit="page" to="25">25</biblScope></imprint><idno type="ISSN">0006-8993</idno></series><idno type="istex">1A3EDCFD79687759F33CB8A711F24AD90AE488FC</idno><idno type="DOI">10.1016/0006-8993(94)01217-6</idno><idno type="PII">0006-8993(94)01217-6</idno><idno type="ArticleID">94012176</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0006-8993</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>6-Hydroxydopamine</term><term>Cerebrospinal fluid</term><term>Dopamine</term><term>MPP+</term><term>Parkinson's disease</term><term>Rat</term><term>Striatum</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Dopamine (DA) and its main cerebral metabolites, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) were measured in striatum and cerebrospinal fluid (CSF) from cisterna magna in rats bilaterally lesioned by intrastriatal administration of 6-hydroxydopamine (6-OHDA) or 1-methyl-4-phenylpyridinium ion (MPP+). 6-OHDA caused a progressive lesion in striatum that is only moderately reflected in the decrease in dopamine metabolite concentration in CSF. MPP+ caused an acute but less selective lesion in the dopamine striatal system, as indicated by a significant reduction in striatal GABA content, followed by a slow recovery in dopamine striatal metabolism and content. The locomotor activity was dramatically reduced in both groups 48 hours after the treatment but remained significantly decreased after two months only in 6-OHDA lesioned animals. A positive correlation was found between HVA CSF concentration and striatal DA content in MPP+ lesioned rats, but not in 6-OHDA lesioned rats. It is concluded that the concentration of dopamine metabolites in CSF can be altered only after a severe striatal lesion: reduction of striatal dopamine content below 50% of normal values and involvement of neuronal or non-neuronal elements other than the dopaminergic system, similarly to the lesions caused by MPP+. These results may partly explain why CSF dopamine metabolites concentrations were significantly decreased both in advanced stages of parkinsonism and in other neurodegenerative disorders.</div></front></TEI><affiliations><list><country><li>Espagne</li></country></list><tree><country name="Espagne"><noRegion><name sortKey="Espino, A" sort="Espino, A" uniqKey="Espino A" first="A." last="Espino">A. Espino</name></noRegion><name sortKey="Ambrosio, S" sort="Ambrosio, S" uniqKey="Ambrosio S" first="S." last="Ambrosio">S. Ambrosio</name><name sortKey="Bartrons, R" sort="Bartrons, R" uniqKey="Bartrons R" first="R." last="Bartrons">R. Bartrons</name><name sortKey="Calopa, M" sort="Calopa, M" uniqKey="Calopa M" first="M." last="Calopa">M. Calopa</name><name sortKey="Espino, A" sort="Espino, A" uniqKey="Espino A" first="A." last="Espino">A. Espino</name><name sortKey="Llorens, J" sort="Llorens, J" uniqKey="Llorens J" first="J." last="Llorens">J. Llorens</name><name sortKey="Rodriguez Farre, E" sort="Rodriguez Farre, E" uniqKey="Rodriguez Farre E" first="E." last="Rodriguez-Farre">E. Rodriguez-Farre</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002346 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002346 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:1A3EDCFD79687759F33CB8A711F24AD90AE488FC
|texte= Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion
}}
| This area was generated with Dilib version V0.6.23. |  |